Association Between EGFR-TKI-Associated Skin Rash and Recorded Mortality in Non-Small Cell Lung Cancer: A Real-World Analysis Accounting for Immortal Time Bias
{{output}}
Purpose: Skin rash during epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy has been associated with better outcomes in non-small cell lung cancer (NSCLC), but previous studies may have overestimated t... ...
